When everyone heard that they were going to raise funds, they all sat up straight. Some people asked, “My lord, do you have a suitable financing partner?”
Masayoshi Kobayashi nodded and said, “Before, Chairman Jiro had been negotiating with Mr. Takehiko Ito, the patriarch of the Ito family, about financing. Surely everyone knows about this?”
Everyone nodded.
Jiro has always wanted to take Ito’s investment, and even wanted to become Ito’s son-in-law, otherwise he would not spend money to name Nanako in the Sanda competition, which has long been known by Kobayashi Pharmaceutical.
Even, everyone is ready for the marriage between Kobayashi Pharmaceutical and the Ito family. Unfortunately, Jiro disappeared before the marriage was officially advanced.
Everyone thought that the cooperation with the Ito family would be terminated, but they did not expect that Masayoshi Kobayashi would now start cooperation with the Ito family.
As a result, everyone immediately became interested and asked excitedly: “Sir, don’t know what kind of valuation the Ito family can give us?”
Masayoshi Kobayashi cleared his throat and said, “Mr. Takehiko Ito of the Ito family is willing to invest US$4.5 billion in Kobayashi Pharmaceutical at a valuation of US$15 billion, which will account for 30% of Kobayashi’s total shares after the investment!”
“Valued at 15 billion USD?!”
Everyone couldn’t help but talk.
In the beginning, Jiro and Ito Takehiko talked about it, but it was not the price.
At that time, Jiro greeted everyone, and his valuation figure was at least US$20 billion.
Why is it suddenly lowered so much now!
Someone questioned: “Mr. President, the Ito family’s previous offer was not so low, why did it shrink so much?”
Someone said, “Yeah! At least 22 billion USD is appropriate? A valuation of 15 billion USD is nothing short of robbery…”
Kobayashi Masayoshi’s expression was a bit ugly, and he said: “You have to figure out that we are facing internal and external troubles. It is not just that the president has disappeared for no reason. Another Weisan has appeared in China. If we don’t hurry up and raise funds at this time, If we wait for JX Weisan to catch us by surprise, then our performance will drop significantly, let alone a valuation of 15 billion USD, even if it is 10 billion USD, it is impossible to get it!”
FAQ Novel
Q: What is Kobayashi Pharmaceutical’s flagship product?
A: Kobayashi’s Weisan is the flagship product of Kobayashi Pharmaceutical.
Q: What is the proposed solution to stay competitive?
A: The company needs to increase investment in drug research and development and upgrade its current products.
What are your thoughts on the chapter? Share them in the discussion below!